Aviva’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-32,349
Closed -$3.74M 1041
2023
Q3
$3.74M Buy
32,349
+8,646
+36% +$1M 0.02% 544
2023
Q2
$2.44M Sell
23,703
-141,111
-86% -$14.5M 0.01% 598
2023
Q1
$18M Sell
164,814
-178,612
-52% -$19.5M 0.08% 360
2022
Q4
$39.1M Buy
343,426
+24,062
+8% +$2.74M 0.19% 117
2022
Q3
$19.8M Buy
319,364
+57,497
+22% +$3.56M 0.11% 243
2022
Q2
$20.9M Buy
261,867
+105,274
+67% +$8.4M 0.11% 242
2022
Q1
$16.5M Buy
156,593
+79,185
+102% +$8.33M 0.08% 297
2021
Q4
$8.34M Buy
77,408
+9
+0% +$970 0.04% 448
2021
Q3
$8.48M Buy
77,399
+7,139
+10% +$782K 0.04% 441
2021
Q2
$6.58M Buy
70,260
+5,557
+9% +$520K 0.03% 509
2021
Q1
$5.96M Buy
+64,703
New +$5.96M 0.03% 482